A Study of mRNA-1020 & mRNA-1030 Seasonal Influenza Vaccines in Healthy

See also
Status	Clinical Trial	Phase
Completed	`NCT01209780` - Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age	Phase 3
Completed	`NCT01180621` - Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children	Phase 2
Completed	`NCT01206686` - The Effect of Time-Slot Scheduling on Flu Vaccination Rates	N/A
Recruiting	`NCT06049927` - A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months	Phase 3
Completed	`NCT04133584` - The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine	Phase 4
Completed	`NCT05566639` - A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older	Phase 3
Completed	`NCT00957996` - Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza	Phase 3
Completed	`NCT01207232` - The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates	N/A
Completed	`NCT01072799` - Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine	Phase 2
Completed	`NCT04997239` - A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old	Phase 4
Completed	`NCT05512494` - Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated	Phase 4
Completed	`NCT01011582` - Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza	N/A
Terminated	`NCT00958776` - A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza	Phase 3
Completed	`NCT00560066` - Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions	Phase 4
Active, not recruiting	`NCT05397223` - A Study of Modified mRNA Vaccines in Healthy Adults	Phase 1
Completed	`NCT04896086` - First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults	Phase 1
Completed	`NCT01342796` - Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects	Phase 2
Completed	`NCT01344057` - Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012	Phase 2
Completed	`NCT00903552` - Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)	Phase 2
Completed	`NCT05827068` - A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults	Phase 1/Phase 2

NCT number	NCT05333289
Study type	Interventional
Source	ModernaTX, Inc.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 6, 2022
Completion date	November 22, 2022

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms